Table IV.
Association between clinicopathological factors and chemotherapeutic efficacy in NSCLC patients.
| The effect of chemotherapy | ||||
|---|---|---|---|---|
|
|
||||
| Variables | SD+PD cases | CR+PR cases | χ2 | P-value |
| Gender | ||||
| Male | 61 | 28 | 0.095 | 0.758 |
| Female | 35 | 18 | ||
| Age (years) | ||||
| ≥52 | 56 | 22 | 0.375 | 0.540 |
| <52 | 40 | 24 | ||
| Smoking | ||||
| Yes | 59 | 20 | 3.377 | 0.066 |
| No | 37 | 26 | ||
| Pathological type | ||||
| Squamous carcinoma | 52 | 30 | ||
| Adenocarcinoma | 44 | 16 | 1.136 | 2.286 |
| Grade | ||||
| High | 22 | 16 | 3.527 | 0.06 |
| Intermidiate | 38 | 20 | ||
| Low | 36 | 10 | ||
| High and intermediate | 60 | 36 | ||
| Clinical stage | ||||
| IIIB | 61 | 35 | 1.699 | 0.192 |
| IV | 35 | 11 | ||
| PS | ||||
| 70 | 30 | 12 | 1.129 | 0.569 |
| 80 | 35 | 15 | ||
| 90 | 31 | 18 | ||
| Chemotherapy regimens | ||||
| DDP+NVB | 49 | 17 | ||
| DDP+TAX | 47 | 29 | 1.946 | 0.163 |
SD, stable disease; PD, progressive disease; CR, complete response; PR, partial response.